Search the Newsreel

Sprott Inc (SII) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts for Sprott Inc (SII), detailing dividend amounts, record dates, payment dates, and ex-dividend dates from February 2024 through May 2026. It highlights that Sprott Inc has distributed a total of 104.34M USD in dividends over …

Protagonist Therapeutics Market Sentiment

This article analyzes the market sentiment for Protagonist Therapeutics (PTGX) based on analyst consensus, short interest, options flow, and insider activity. The analyst consensus is "Buy" with 18 analysts, and the average price target is $104. Short interest is 13.9% and declining, which is …

Walleye Capital LLC Boosts Position in Protara Therapeutics, Inc. $TARA

Walleye Capital LLC significantly increased its stake in Protara Therapeutics, Inc. (NASDAQ:TARA) by 204% in the first quarter of 2026, bringing its total holdings to 443,401 shares valued at $2.31 million. Other institutional investors also modified their positions, with hedge funds and institutional investors …

Sprott Physical Uranium Trust Revenue Breakdown – TSX:U.UN

Top Growth Companies With Insider Ownership For July 2026

This article identifies top growth companies in the United States with significant insider ownership, highlighting that high insider ownership aligns management's interests with shareholders. It provides a list of 10 such companies and then delves deeper into three examples: Kingstone Companies (KINS), Prothena (PRTA), …

Latest FUND ETF News Today | Earnings, Events & Price Alerts

This page provides the latest news, earnings, events, and price alerts for the FUND ETF. It aggregates recent articles from sources like NASDAQ.COM, Newsfilter, Globenewswire, and SeekingAlpha, discussing topics such as Sprott Focus Trust's distributions, insider buying analysis, and commodity market trends. The content …

IPM|Intelligent Protection Management Corp|Price:1.770|Chg%:-0.030

Intelligent Protection Management Corp (IPM), formerly Paltalk, Inc., specializes in providing server hosting, cloud hosting, data storage, managed security, backup, and disaster recovery services. The company's solutions include Private and Hybrid Cloud, Managed Security, Managed Backup and Disaster Recovery, and Private Cloud AI. As …

Sprott Inc (SII) Cash Flow

This article provides a comprehensive overview of Sprott Inc's (SII) cash flow, including detailed quarterly and annual statements for operating, investing, and financing activities. It presents financial figures such as net income, capital expenditures, and dividend payments, alongside year-over-year percentage changes. The article also …

Proto Labs Inc (PRLB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Proto Labs Inc (PRLB) by business segment and geographical region, updated as of April 6. It highlights that CNC Machining (Firstcut) is the largest segment, contributing 45.64% of revenue, followed by Injection Molding (Protomold) at 35.92%. …

Protagonist Therapeutics Inc (PTGX) Earnings Forecast: Future EPS & Revenue Growth Estimates

Protagonist Therapeutics Inc (PTGX) has an earnings forecast score of 8.57, ranking 98th in the Biotechnology & Medical Research industry. Analysts have an average price target of $91.00 for PTGX, with most analysts recommending a "Buy" rating. The company's expected revenue for the next …

Protara Therapeutics Inc (TARA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on the dividend and stock split history for Protara Therapeutics Inc (TARA). It states that the company has not distributed any dividends over the past five years. Key financial data like market cap and current stock price are also presented.

Protara Therapeutics Inc (TARA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Protara Therapeutics Inc (TARA). It states that relevant data regarding business segments, regional revenue, and profit contribution for FY2019 have not been disclosed by the company yet. The article indicates a market cap of $222.36 …

Prothena (PRTA) Expected to Announce Quarterly Earnings on Monday

Protagonist Therapeutics Inc (PTGX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Protagonist Therapeutics Inc (PTGX) regarding its dividend history and stock splits. It indicates that the company has not distributed any dividends over the past five years. The page also presents current stock performance data, including its market cap.

Sprott Inc (SII) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sprott Inc (SII), including a breakdown of major shareholders and institutional holdings. It lists the top individual and corporate shareholders by proportion, categorizes shareholder types, and provides a historical overview of institutional shareholding changes. The article also …

Prothena Corporation PLC (PRTA) Institutional Confidence

Prothena Corporation PLC (PRTA) has an institutional shareholding score of 10.00, placing it first in the Biotechnology & Medical Research industry. Institutional shareholding stands at 96.24%, an increase of 19.52% quarter-over-quarter. James Simons is the largest institutional shareholder, holding 1.14% of shares outstanding.

Proto Labs Inc (PRLB) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Proto Labs Inc (PRLB), listing its major institutional holders and their respective proportions. It also presents institutional shareholding trends over several quarters and recent shareholder activity with changes in holdings for key investors. Additionally, the article identifies …

Proto Labs Inc (PRLB) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Proto Labs Inc (PRLB), detailing its current earnings forecast score, analyst ratings, and price targets. It includes an overview of the company's financial health, valuation, and institutional confidence, along with FAQs regarding expected revenue and EPS performance. …

Proto Labs (PRLB) Stock Still Looks Stretched Despite Its 139% Run

Sprott Focus Trust (FUND) Edges Lower Amid Light Trading - Post-Earnings Moves

Sprott Inc. Revenue Breakdown – GETTEX:A781

Sprott Inc. generated a total revenue of 242.72 million EUR last year. Its top-performing segment, Exchange Listed Products, contributed 97.85 million EUR, an increase from 75.52 million EUR in the previous year. Canada was the primary regional contributor, accounting for 137.88 million EUR of …

Protagonist Therapeutics, Inc. Revenue Breakdown – NASDAQ:PTGX

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) generated $46.02 million in revenue last year, primarily from its Peptide Therapeutics segment, a significant decrease from the previous year's $434.43 million. The United States was the company's largest contributor to revenue.

Does TARA Stock’s 15% After-Hours Slump Signal A Bargain After New Bladder Cancer Data?

Protara Therapeutics (TARA) saw its stock drop nearly 15% after hours despite reporting strong efficacy and a favorable safety profile from its Phase 2 Advanced-2 bladder cancer trial. The data showed high complete response rates in both BCG-unresponsive and BCG-naive patients. Analysts remain bullish …

Proto Labs, Inc. Revenue Breakdown – LSX:A1JUHT

Proto Labs, Inc. (A1JUHT) generated 453.91 million EUR in revenue last year, with its Computer Numerical Control Machining segment contributing the most at 207.17 million EUR. The majority of its revenue, 368.09 million EUR, originated from the United States. This indicates the primary segment …

SII|Sprott Inc|Price:102.840|Chg%:-2.710

This article provides a detailed analysis of Sprott Inc (SII) using TradingKey's Stock Score system. It highlights the company's strong fundamentals, high growth potential, and stable dividend payments, despite recent stock market performance and its "fairly valued" classification. The analysis also covers institutional ownership, …

Sprott Inc. $SII Shares Sold by Cannell & Spears LLC

Protara Therapeutics Inc (TARA) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Protara Therapeutics Inc (TARA), detailing its volatility, financial risks, and investment risks. TARA has a risk assessment score of 3.34, ranking it 138 out of 386 in the Biotechnology & Medical Research industry, and exhibits a beta …

Protagonist Therapeutics, Inc. $PTGX Shares Sold by Atika Capital Management LLC

Atika Capital Management LLC reduced its stake in Protagonist Therapeutics (NASDAQ:PTGX) by 27.8% in Q1 2026, selling 23,900 shares, though institutional ownership remains high at 98.63%. Despite Atika's sale, other major institutional investors like Vanguard, State Street, and Wellington increased their positions. Analysts maintain …

Prothena Corporation PLC (PRTA) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Prothena Corporation PLC (PRTA), detailing its current risk score, beta value, and various volatility metrics. PRTA has a risk assessment score of 5.28, ranking 46 out of 386 in the Biotechnology & Medical Research industry, with a …

FUND Technical Analysis & ETF Price Forecast

This article provides a technical analysis and price forecast for Sprott Focus Trust Inc (FUND), indicating a "Strong buy" consensus based on various technical signals. It details momentum indicators, support/resistance levels, and moving averages, with the current share price of $9.84 showing both buy …

Prothena Corporation plc Revenue Breakdown – NASDAQ:PRTA

Prothena Corporation plc (NASDAQ: PRTA) generated $9.68 million USD in revenue last year. The majority of this, $9.63 million USD, came from its Collaboration segment, a decrease from $135.11 million USD the previous year. The United States was the company's primary revenue source.

Protagonist Therapeutics (PTGX) Stock Looks Stretched As A Price Target Boost Lands

Protagonist Therapeutics (PTGX) has seen a significant 7x return over the last three years, leading to a stretched valuation despite a recent price target boost from Barclays. The stock appears overvalued on market multiples and shows a mixed picture on broader valuation checks, raising …

Sprott Focus Trust (NASDAQ:FUND) Stock Passes Above 50 Day Moving Average - Time to Sell?

Sprott Focus Trust (NASDAQ:FUND) shares have risen above their 50-day moving average, trading as high as $9.92 before settling at $9.83. The trust recently increased its quarterly dividend to $0.1424 per share, offering an annualized yield of about 5.8%. Insider W. Whitney George also …

PRLB|Proto Labs Inc|Price:78.730|Chg%:+0.490

This article provides an overview of Proto Labs Inc (PRLB) stock, including real-time quotes, market trends, and analysis. It highlights the company's strong fundamentals and high growth potential, alongside its valuation and institutional ownership. The report also includes analyst ratings, key financial figures, and …

Sprott Inc. (SII) Declines 2.66% as Precious Metals Sector Faces Headwinds - Merger Arbitrage

Proto Labs (PRLB) Projected to Post Earnings on Friday